Showing 931-940 of 8860 results for "".
Developing PsA: Risk Factors for Psoriasis Patients
https://practicaldermatology.com/topics/psoriasis/developing-psa-risk-factors-for-psoriasis-patients/19651/Can patients with psoriasis lessen their chance of developing psoriatic arthritis? Ronald Prussick, MD discusses the known risk factors and the importance of weight and a low BMI for these patients. He also talks about non-alcoholic fatty liver syndrome in this patient population.PsO Treatment Guidelines: The Role of Systemic Medications
https://practicaldermatology.com/topics/psoriasis/pso-treatment-guidelines-the-role-of-systemic-medications/19649/Biologics and new JAK inhibitors play an important role in managing psoriasis. Neal Bhatia, MD offers his thoughts on when and why these treatments should be considered.Avoid the Three Most Common Asset Protection Mistakes
https://practicaldermatology.com/topics/practice-management/avoid-the-three-most-common-asset-protection-mistakes/18368/OJM Group principal David Mandell, JD, MBA discusses the importance of protecting personal and business assets from lawsuits, and outlines strategies to avoid the three asset protection mistakes made by most doctors. Click here to request or download a free copy of Wealth Protection Planning for DeIncorporating Cosmetic Dermatology into Your Medical Practice
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/incorporating-cosmetic-dermatology-into-your-medical-practice/18763/Cosmetic Dermatology experts Gary D. Monheit, MD, Nancy J. Samolitis, MD, and Joel L. Cohen, MD share tips for adding aesthetic offerings to an established medical dermatology practice or for young physicians opening a new practice. Sitting down with host Neal Bhatia, MD, they all emphasize the impoM22™ with ResurFX™ - A User's Perspective
https://practicaldermatology.com/topics/general-topics/m22-with-resurfx-a-user-s-perspective/18803/Dr. Palm shares her perspective on the M22 IPL system with non-ablative one-pass resurfacing, and why it is one of the most popular procedures in her clinic.Gold's Standards: Nashville's Laser Guru on Best Practices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/gold-s-standards-nashville-s-laser-guru-on-best-practices/18867/When a third of your practice is dedicated to energy-based devices, it's important to find the best solutions for your patient flow. In this edition of Best Practices, Joel L. Cohen, MD talks to Michael H. Gold, MD about his approach to adoption and promotion of energy-based devices. Dr. Gold discusSkin cancer: Coach's toughest opponent: PSA
https://practicaldermatology.com/topics/skin-cancer-photoprotection/skin-cancer-coach-s-toughest-opponent-psa/18922/Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network project. The PSA and video feature Division I college women's basketball coach Lisa Pace, who blames her indoor tanning habit for the development of more than 80 skin cancers, five ofGuys, Don't Be Like Paul:Â PSA
https://practicaldermatology.com/topics/skin-cancer-photoprotection/guys-don-t-be-like-paul-psa/18924/Dr. Terrence Keaney created this PSA for his American Society for Dermatologic Surgery (ASDS) Future Leaders Network project. The first PSA and video focuses specifically on men and features Dr. Keaney. Data from the Skin Cancer Foundation cited by ASDS show that only 30 percent of American men areMultiplexed 1,440 and 1,320 nm Laser for Chronic Photodamage
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/multiplexed-1-440-and-1-320-nm-laser-for-chronic-photodamage/19352/Dr. Bernstein discusses the benefits of a multiplexed dual wavelength non-ablative laser for treatment of photodamage.An Inside Look at How Incyte is Addressing Unmet Needs of Patients with Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/an-inside-look-at-how-incyte-is-addressing-unmet-needs-of-patients-with-atopic-dermatitis/20156/Ahmad Naim, Vice President of US Medical Affairs at Incyte, discusses the challenges around atopic dermatitis (AD) management and how Incyte is utilizing its expertise in immunology to address unmet needs for patients.